Breast cancer is the second most common cancer among women in the United States today. Now, advanced technologies originally developed at the DOE's Thomas Jefferson National Accelerator Facility (Jefferson Lab) for studying the tiniest particles inside matter have been adapted to aid doctors in diagnosis and treatment of breast cancer patients.
